These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


425 related items for PubMed ID: 19254961

  • 1. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S, Habuchi H, Sugaya N, Kobayashi T, Kimata K.
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [Abstract] [Full Text] [Related]

  • 2. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC, Rahimi N, Forsten-Williams K, Nugent MA.
    Circ Res; 2004 Feb 20; 94(3):316-23. PubMed ID: 14684627
    [Abstract] [Full Text] [Related]

  • 3. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL, Kan M.
    Mol Reprod Dev; 1994 Sep 20; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
    Delehedde M, Lyon M, Gallagher JT, Rudland PS, Fernig DG.
    Biochem J; 2002 Aug 15; 366(Pt 1):235-44. PubMed ID: 12000311
    [Abstract] [Full Text] [Related]

  • 5. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ, Parish CR, McGarry M, Santiago FS, Lowe HC, Brown KJ, Bingley JA, Hayward IP, Cowden WB, Campbell JH, Campbell GR, Chesterman CN, Khachigian LM.
    Circ Res; 2003 May 02; 92(8):e70-7. PubMed ID: 12690039
    [Abstract] [Full Text] [Related]

  • 6. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
    Luo Y, Ye S, Kan M, McKeehan WL.
    J Cell Biochem; 2006 Apr 15; 97(6):1241-58. PubMed ID: 16315317
    [Abstract] [Full Text] [Related]

  • 7. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K, Chua CC, Nugent MA.
    J Theor Biol; 2005 Apr 21; 233(4):483-99. PubMed ID: 15748910
    [Abstract] [Full Text] [Related]

  • 8. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
    Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M, Claesson-Welsh L.
    J Biol Chem; 2000 Aug 11; 275(32):24653-60. PubMed ID: 10816596
    [Abstract] [Full Text] [Related]

  • 9. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
    Mohammadi M, Olsen SK, Goetz R.
    Curr Opin Struct Biol; 2005 Oct 11; 15(5):506-16. PubMed ID: 16154740
    [Abstract] [Full Text] [Related]

  • 10. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
    Harmer NJ.
    Biochem Soc Trans; 2006 Jun 11; 34(Pt 3):442-5. PubMed ID: 16709182
    [Abstract] [Full Text] [Related]

  • 11. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
    Zhou FY, Kan M, Owens RT, McKeehan WL, Thompson JA, Linhardt RJ, Höök M.
    Eur J Cell Biol; 1997 May 11; 73(1):71-80. PubMed ID: 9174673
    [Abstract] [Full Text] [Related]

  • 12. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
    Rudd TR, Uniewicz KA, Ori A, Guimond SE, Skidmore MA, Gaudesi D, Xu R, Turnbull JE, Guerrini M, Torri G, Siligardi G, Wilkinson MC, Fernig DG, Yates EA.
    Org Biomol Chem; 2010 Dec 07; 8(23):5390-7. PubMed ID: 20865198
    [Abstract] [Full Text] [Related]

  • 13. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V.
    Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174
    [Abstract] [Full Text] [Related]

  • 14. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY, Qi Y, Wang B, Lazar V, Wang J, Fraser Symmans W, Hortobagyi GN, Andre F, Pusztai L.
    Breast Cancer Res Treat; 2010 Oct 15; 123(3):747-55. PubMed ID: 20024612
    [Abstract] [Full Text] [Related]

  • 15. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ, Fritz TA, Esko JD, Zimmermann J, Yayon A, Vlodavsky I.
    J Cell Biochem; 1995 Feb 15; 57(2):173-84. PubMed ID: 7759555
    [Abstract] [Full Text] [Related]

  • 16. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
    Moy FJ, Safran M, Seddon AP, Kitchen D, Böhlen P, Aviezer D, Yayon A, Powers R.
    Biochemistry; 1997 Apr 22; 36(16):4782-91. PubMed ID: 9125499
    [Abstract] [Full Text] [Related]

  • 17. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.
    Francavilla C, Loeffler S, Piccini D, Kren A, Christofori G, Cavallaro U.
    J Cell Sci; 2007 Dec 15; 120(Pt 24):4388-94. PubMed ID: 18042627
    [Abstract] [Full Text] [Related]

  • 18. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
    Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K.
    J Biol Chem; 2004 Mar 26; 279(13):12346-54. PubMed ID: 14707131
    [Abstract] [Full Text] [Related]

  • 19. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
    Aviezer D, Safran M, Yayon A.
    Biochem Biophys Res Commun; 1999 Oct 05; 263(3):621-6. PubMed ID: 10512728
    [Abstract] [Full Text] [Related]

  • 20. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
    Foxall C, Wei Z, Schaefer ME, Casabonne M, Fugedi P, Peto C, Castellot JJ, Brandley BK.
    J Cell Physiol; 1996 Sep 05; 168(3):657-67. PubMed ID: 8816920
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.